← Back to Analyst Consensus 
ALMR Buy
Alamar Biosciences, Inc.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 11, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Aug 11, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| May 12, 2026 | Leerink Partners | initiate | — → Outperform | — | 51% |
| May 12, 2026 | TD Cowen | initiate | — → Buy | — | 54% |
| May 12, 2026 | JP Morgan | initiate | — → Overweight | — | 54% |
| May 12, 2026 | Stifel | initiate | — → Buy | — | 53% |
Price Target Trend
May 20, 2026 Oct 26, 2026
EPS Estimates
+1y —
+1q —
0q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days